JeffreyMStatlandMD

PubMed

• Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
  Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme, Florian P Thomas, Carlos Casanovas, Jafar Kafaie, Céline Tard, Maggie C Walter, Yann ...> ;Orphanet Journal of Rare Diseases. 2024 Apr 1
• Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study.
  Amy Doody, Lindsay Alfano, Jordi Diaz-Manera, Linda Lowes, Katherine D Mathews, Matthew Wicklund, Man Hung, Nicholas E Johnson, , Tahseen Mozaffar, Conrad C Weihl, Jef...> ;BMC Neurology. 2024 Mar 15
• Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
  Chao-Jen Wong, Seth D Friedman, Lauren Snider, Sean R Bennett, Takako I Jones, Peter L Jones, Dennis W W Shaw, Silvia S Blemker, Lara Riem, Olivia DuCharme, Richard J ...> ;Human Molecular Genetics. 2024 Apr 8
• A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
  Varma, A., Eichinger, K., Heininger, S., Dilek, N., Martens, W., McDermott, M., Heatwole, C., Todinca, M., Tawil, R., Statland, J., Kissel, J.> ;Muscle & Nerve. 2024 Mar 1
• Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagiline.
  Simon Witzel, Jeffrey M Statland, Petra Steinacker, Markus Otto, Johannes Dorst, Joachim Schuster, Richard J Barohn, Albert C Ludolph> ;European Journal of Neurology. 2024 Mar 1
• Temporal course of cognitive and behavioural changes in motor neuron diseases.
  Caroline A McHutchison, Joanne Wuu, Corey T McMillan, Rosa Rademakers, Jeffrey Statland, Gang Wu, Evadnie Rampersaud, Jason Myers, Jessica P Hernandez, Sharon Abrahams...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2024 Mar 13
• 2 citations
  Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.
  Richard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, Jan L de Bleecker, Ludo van der Pol, Diane M Dunn, Corrie E Erasmus, Marc D'Hooghe, Kristof Verhoe...> ;Brain. 2024 Feb 1
• The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure.
  Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Christine Zizzi, Danae Alexandrou, Ellen Wagner, Nuran Dilek, John Heatwole, Joanne Wuu, James Caress...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Aug 1
• 6 citations
  Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
  Charles A Thornton, Richard Thomas Moxley 3rd, Katy Eichinger, Chad Heatwole, Laurence Mignon, W David Arnold, Tetsuo Ashizawa, John W Day, Gersham Dent, Matthew K Tan...> ;The Lancet. Neurology. 2023 Mar 1
• 1 citations
  Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
  Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J Silvestri, Milind Phadnis, Hans D Katzberg, David S Saperstein, Gil I Wolfe, Laura Herbelin, Kiley Hi...> ;European Journal of Neurology. 2023 May 1
• 6 citations
  Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
  Mara S Tihaya, Karlien Mul, Judit Balog, Jessica C de Greef, Stephen J Tapscott, Rabi Tawil, Jeffrey M Statland, Silvère M van der Maarel> ;Nature Reviews. Neurology. 2023 Feb 1
• 5 citations
  Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional study.
  Christine Zizzi, Jamison Seabury, Spencer Rosero, Danae Alexandrou, Ellen Wagner, Jennifer S Weinstein, Anika Varma, Nuran Dilek, John Heatwole, Joanne Wuu, James Care...> ;Eclinicalmedicine. 2023 Jan 1
• 1 citations
  Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.
  Heloise M Hoffmann, Victor Malo-Juvera, Jeffrey M Statland> ;Muscle & Nerve. 2022 Oct 1
• 8 citations
  Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.
  Jeffrey M Statland, Craig Campbell, Urvi Desai, Chafic Karam, Jordi Díaz-Manera, Jeffrey T Guptill, Lawrence Korngut, Angela Genge, Rabi N Tawil, Lauren Elman, Nanette...> ;Muscle & Nerve. 2022 Jul 1
• 1 citations
  Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.
  Swathy Chandrashekhar, Anai C Hamasaki, Rebecca Clay, Ayla McCalley, Laura Herbelin, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, Richard J Barohn, Jeffrey Statland> ;Muscle & Nerve. 2022 Jul 1
• Reply: Wheelchair use in genetically confirmed FSHD1 from a large cohort study in Chinese population.
  Natalie K Katz, John Hogan, Ryan Delbango, Colin Cernik, Rabi Tawil, Jeffrey M Statland> ;Brain. 2022 Jun 30
• 8 citations
  Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
  Michelle L Mellion, Per Widholm, Markus Karlsson, André Ahlgren, Rabi Tawil, Kathryn R Wagner, Jeffrey M Statland, Leo Wang, Perry B Shieh, Baziel G M van Engelen, Joo...> ;Neurology. 2022 Aug 30
• 8 citations
  Elevated plasma complement components in facioscapulohumeral dystrophy.
  Chao-Jen Wong, Leo Wang, V Michael Holers, Ashley Frazer-Abel, Silvère M van der Maarel, Rabi Tawil, Jeffrey M Statland, Stephen J Tapscott> ;Human Molecular Genetics. 2022 Jun 4
• 1 citations
  Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.
  Timothy R Fullam, Swathy Chandrashekhar, Constantine Farmakidis, Omar Jawdat, Mamatha Pasnoor, Mazen M Dimachkie, Jeffrey M Statland> ;Muscle & Nerve. 2022 Aug 1
• 2 citations
  Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatab...
  Per Widholm, André Ahlgren, Markus Karlsson, Thobias Romu, Rabi Tawil, Kathryn R Wagner, Jeffrey M Statland, Leo H Wang, Perry B Shieh, Baziel G M van Engelen, Diego C...> ;Muscle & Nerve. 2022 Aug 1
• 3 citations
  Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
  Gayle K Deutsch, Katharine A Hagerman, Jacinda Sampson, Gersham Dent, Jeanne Dekdebrun, Dana M Parker, Charles A Thornton, Chad R Heatwole, Sub H Subramony, Ami K Mank...> ;Muscle & Nerve. 2022 May 1
• 38 citations
  Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
  Michela Guglieri, Kate Bushby, Michael P McDermott, Kimberly A Hart, Rabi Tawil, William B Martens, Barbara E Herr, Elaine McColl, Chris Speed, Jennifer Wilkinson, Jan...> ;JAMA. 2022 Apr 19
• 11 citations
  Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy.
  Ortiz Guerrero, G., Megan A Waldrop, Steven A Moore, Katherine D Mathews, Benjamin W Darbro, Livja Medne, Richard Finkel, Anne M Connolly, Thomas O Crawford, Daniel Dr...> ;Human Mutation. 2022 Apr 1
• 3 citations
  Understanding the Perseverance of the Muscular Dystrophy Community One-Year into the COVID-19 Pandemic.
  Leann Lewis, Katy Eichinger, Nuran Dilek, Kiley Higgs, Michaela Walker, David Palmer, John M Cooley, Nicholas Johnson, Rabi Tawil, Jeffrey Statland> ;Journal of Neuromuscular Diseases. 2022 Jan 1
• 48 citations
  Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
  Jordi Diaz-Manera, Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub, Antonio Toscano, Ans T. van der Ploeg, Kenneth I. Berger, Paula R. ...> ;The Lancet. Neurology. 2021 Dec 1
• Join now to see all